Skip to content
DraconiticResearch
Search Sources API
194,164 studies31 sourcesUpdated 8 min ago
Peer-reviewedCC BYNature Genetics

Consensus meta-analysis of genome-wide association studies for Alzheimer’s disease and related dementias

88 more authors

60 listed; 100 in total.

40 affiliations
  1. 1Univ. Lille , Inserm , CHU Lille , Institut Pasteur Lille , LabEx DISTALZ-U1167- RID-AGE Facteurs de Risque et Déterminants Moléculaires des Maladies Liées au Vieillissement , Lille , France
  2. 2Univ. Lille, Inserm, CHU Lille, Institut Pasteur Lille, LabEx DISTALZ—U1167-RID-AGE Facteurs de Risque et Déterminants Moléculaires des Maladies Liées au Vieillissement, Lille, France
  3. 3UKDRI@ Cardiff, School of Medicine, Cardiff University, Cardiff, UK
  4. 4Nuffield Department of Population Health, University of Oxford, Oxford, UK
  5. 5Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, The Netherlands
  6. 6Amsterdam Neuroscience, Neurodegeneration, Amsterdam, The Netherlands
  7. 7Department of Complex Trait Genetics, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, Vrije University, Amsterdam, The Netherlands
  8. 8Department of Cognitive Disorders and Old Age Psychiatry, University Hospital Bonn, Medical Faculty, Bonn, Germany
  9. 9Division of Neurogenetics and Molecular Psychiatry, Department of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
  10. 10Complex Genetics of Alzheimer’s Disease Group, VIB Center for Molecular Neurology, VIB, Antwerp, Belgium
  11. 11Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
  12. 12Institute of Biomedicine, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland
  13. 13Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya (UIC), Barcelona, Spain
  14. 14Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain
  15. 15Estudios en Neurociencias y Sistemas Complejos (ENyS) CONICET-HEC-UNAJ, Florencio Varela, Argentina
  16. 16Department of Neurodegeneration and Geriatric Psychiatry, University of Bonn, Bonn, Germany
  17. 17German Center for Neurodegenerative Diseases (DZNE Bonn), Bonn, Germany
  18. 18German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany
  19. 19Institute of Psychiatry and Psychotherapy, Charité—Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt Universität zu Berlin and Berlin Institute of Health, Berlin, Germany
  20. 20Department of Cognitive Disorders and Old Age Psychiatry, University Hospital Bonn, Venusberg-Campus 1, Bonn, Germany
  21. 21German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany
  22. 22German Center for Neurodegenerative Diseases (DZNE), Munich, Germany
  23. 23Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany
  24. 24Munich Cluster for Systems Neurology (SyNergy), Munich, Germany
  25. 25Martin-Luther-University Halle-Wittenberg, University Clinic and Outpatient Clinic for Psychiatry, Psychotherapy and Psychosomatics, Halle (Saale), Germany
  26. 26LVR-University Hospital Essen, Department of Psychiatry and Psychotherapy, Medical Faculty, University of Duisburg-Essen, Essen, Germany
  27. 27Department of Psychiatry, Psychosomatics and Psychotherapy, Center of Mental Health, University Hospital of Würzburg, Würzburg, Germany
  28. 28Institute of Social Medicine, Occupational Health and Public Health, University of Leipzig, Leipzig, Germany
  29. 29Department of Geriatric Psychiatry, Central Institute for Mental Health Mannheim, Faculty Mannheim, University of Heidelberg, Mannheim, Germany
  30. 30Alzheimer’s Disease and Other Cognitive Disorders Unit, Service of Neurology, Hospital Clínic of Barcelona, Institut d’Investigacions Biomèdiques August Pi i Sunyer, Institute of Neurosciences of the University of Barcelona, Barcelona, Spain
  31. 31Neurological Tissue Bank - Biobanc - Hospital Clínic - IDIBAPS, Barcelona, Spain
  32. 32German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany
  33. 33Institute of Cognitive Neurology and Dementia Research (IKND), Otto-von-Guericke University, Magdeburg, Germany
  34. 34Center for Cognitive Disorders, Department of Psychiatry and Psychotherapy, Technical University of Munich, School of Medicine, Munich, Germany
  35. 35Department of Psychiatry and Psychotherapy, University Medical Center Goettingen, Goettingen, Germany
  36. 36German Center for Neurodegenerative Diseases (DZNE), Goettingen, Germany
  37. 37Medical Science Department, iBiMED, Aveiro, Portugal
  38. 38Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany
  39. 39Institute for Urban Public Health, University Hospital of University Duisburg-Essen, Essen, Germany
  40. 40German Center for Neurodegenerative Diseases (DZNE, Bonn), Bonn, Germany

Abstract

To better characterize the genetic architecture underlying Alzheimer's disease (AD) and related dementias (ADRD), we performed a meta-analysis of European-ancestry genome-wide association studies in 128,681 cases or proxy cases of ADRD and 849,833 (proxy) controls. We identified 91 genetic loci associated with ADRD risk, of which 16 are new and 56 are specifically detected in clinically diagnosed AD cases. We also provide a list of 18 loci (15 new) requiring further external validation. A polygenic score combining the effects of ADRD loci other than APOE was primarily associated with AD rather than non-AD pathology. Individuals in the tenth decile of the score exhibited a twofold increased risk of presenting with Braak neurofibrillary tangles stage of >4 and moderate-to-severe neuritic amyloid plaque pathology at death compared to individuals in the median score group. In conclusion, our study validated a large number of loci associated with the risk of clinically diagnosed AD, while further investigations are required to confirm the impact of the other loci on AD clinical diagnosis and of each locus on AD pathology.

Related

  1. ARSA: an autonomous research scientist for target nomination in Alzheimer's disease and related dementias
    X. Li, J. Liu, J. Liu +8
    bioRxivPreprintCC BY-NC-NDFull textBioinformatics & computational biologybioRxiv
  2. Association of temporal and masseter muscle thickness with cognitive function and clinical severity in Alzheimer’s disease: a retrospective study
    Jing Li, Xingqi Xiang, Siyu Long +2
    Frontiers in neurosciencePeer-reviewedCC BYFull textNeuroscienceEurope PMC
  3. Zika virus infection induces a persistent accumulation of Alzheimer’s disease-like Tau phosphorylation in adult immunocompetent mice in association with memory and social behavior impairments
    Gaetano Calcagno, Zeyni Mansuroglu, Helena Segrt +10
    Acta Neuropathologica CommunicationsPeer-reviewedCC BY-NC-ND 4.0Full textMicrobiologyHAL
  4. The consensus-based CINEX guideline for reporting clinical information extraction studies
    Daniel Reichenpfader, Jamil Zaghir, Elsa Cecilia-Joseph +9
    Journal of the American Medical Informatics AssociationPeer-reviewedCC BY 4.0Full text1 citedSystems & synthetic biologyHAL
  5. The Management of Type 1 Diabetes in Adults. The Updated 2026 Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
    Richard I.G. Holt, J. Hans Devries, Amy Hess-Fischl +11
    Diabetes CarePeer-reviewedLicence not statedFull text1 citedGeneral biologyEndocrinology & metabolismHAL
BibTeX
@article{biobank2026consensus,
  title = {{Consensus meta-analysis of genome-wide association studies for Alzheimer’s disease and related dementias}},
  author = {EADB (Alzheimer Disease European DNA biobank) and Céline Bellenguez and Atahualpa Castillo-Morales and Najaf Amin and Sven J. van der Lee and Manon Muntaner and Kayenat Parveen and Fahri Küçükali and Benjamin Grenier‐Boley and Sami Heikkinen and Itziar de Rojas and Maria Carolina Dalmasso and Luca Kleineidam and Oliver Peters and Anja Schneider and Martin Dichgans and Dan Rujescu and Norbert Scherbaum and Jürgen Deckert and Steffi Riedel-Heller and Lucrezia Hausner and Laura Molina‐Porcel and Emrah Düzel and Timo Grimmer and Jens Wiltfang and Stefanie Heilmann‐Heimbach and Susanne Moebus and Matthias Schmid and Thomas Tegos and Nikolaos Scarmeas and Oriol Dols‐Icardo and Fermín Moreno and Jordi Pérez‐Tur and María José Bullido and Pau Pástor and Raquel Sánchez‐Valle and Victoria Álvarez and Merçé Boada and Pablo García‐González and Raquel Puerta and Pablo Mir and Luis M. Real and Gerard Piñol‐Ripoll and José María García‐Alberca and Eloy Rodríguez‐Rodríguez and Hilkka S. Soininen and Alexandre de Mendonça and Shima Mehrabian and Jakub Hort and Martin Vyhnálek and Nicolai Sandau and Jiao Luo and Jesper Qvist Thomassen and Yolande A.L. Pijnenburg and Wiesje M. van der Flier and Harro Seelaar and Inez H.G.B. Ramakers and Janne M. Papma and Marc Hulsman and Gert-Jan Biessels},
  journal = {Nature Genetics},
  year = {2026},
  month = jun,
  doi = {10.1038/s41588-026-02583-1},
  url = {https://doi.org/10.1038/s41588-026-02583-1},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Consensus meta-analysis of genome-wide association studies for Alzheimer’s disease and related dementias
AU  - EADB (Alzheimer Disease European DNA biobank)
AU  - Céline Bellenguez
AU  - Atahualpa Castillo-Morales
AU  - Najaf Amin
AU  - Sven J. van der Lee
AU  - Manon Muntaner
AU  - Kayenat Parveen
AU  - Fahri Küçükali
AU  - Benjamin Grenier‐Boley
AU  - Sami Heikkinen
AU  - Itziar de Rojas
AU  - Maria Carolina Dalmasso
AU  - Luca Kleineidam
AU  - Oliver Peters
AU  - Anja Schneider
AU  - Martin Dichgans
AU  - Dan Rujescu
AU  - Norbert Scherbaum
AU  - Jürgen Deckert
AU  - Steffi Riedel-Heller
AU  - Lucrezia Hausner
AU  - Laura Molina‐Porcel
AU  - Emrah Düzel
AU  - Timo Grimmer
AU  - Jens Wiltfang
AU  - Stefanie Heilmann‐Heimbach
AU  - Susanne Moebus
AU  - Matthias Schmid
AU  - Thomas Tegos
AU  - Nikolaos Scarmeas
AU  - Oriol Dols‐Icardo
AU  - Fermín Moreno
AU  - Jordi Pérez‐Tur
AU  - María José Bullido
AU  - Pau Pástor
AU  - Raquel Sánchez‐Valle
AU  - Victoria Álvarez
AU  - Merçé Boada
AU  - Pablo García‐González
AU  - Raquel Puerta
AU  - Pablo Mir
AU  - Luis M. Real
AU  - Gerard Piñol‐Ripoll
AU  - José María García‐Alberca
AU  - Eloy Rodríguez‐Rodríguez
AU  - Hilkka S. Soininen
AU  - Alexandre de Mendonça
AU  - Shima Mehrabian
AU  - Jakub Hort
AU  - Martin Vyhnálek
AU  - Nicolai Sandau
AU  - Jiao Luo
AU  - Jesper Qvist Thomassen
AU  - Yolande A.L. Pijnenburg
AU  - Wiesje M. van der Flier
AU  - Harro Seelaar
AU  - Inez H.G.B. Ramakers
AU  - Janne M. Papma
AU  - Marc Hulsman
AU  - Gert-Jan Biessels
PY  - 2026
DA  - 2026/06/01
JO  - Nature Genetics
DO  - 10.1038/s41588-026-02583-1
UR  - https://doi.org/10.1038/s41588-026-02583-1
AB  - To better characterize the genetic architecture underlying Alzheimer's disease (AD) and related dementias (ADRD), we performed a meta-analysis of European-ancestry genome-wide association studies in 128,681 cases or proxy cases of ADRD and 849,833 (proxy) controls. We identified 91 genetic loci associated with ADRD risk, of which 16 are new and 56 are specifically detected in clinically diagnosed AD cases. We also provide a list of 18 loci (15 new) requiring further external validation. A polygenic score combining the effects of ADRD loci other than APOE was primarily associated with AD rather than non-AD pathology. Individuals in the tenth decile of the score exhibited a twofold increased risk of presenting with Braak neurofibrillary tangles stage of >4 and moderate-to-severe neuritic amyloid plaque pathology at death compared to individuals in the median score group. In conclusion, our study validated a large number of loci associated with the risk of clinically diagnosed AD, while further investigations are required to confirm the impact of the other loci on AD clinical diagnosis and of each locus on AD pathology.
SN  - 1061-4036
SN  - 1546-1718
ER  -